Terms: = Colorectal cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Prognosis
56 results:
1. Biomarkers to predict efficacy of immune checkpoint inhibitors in colorectal cancer patients: a systematic review and meta-analysis.
Yu H; Liu Q; Wu K; Tang S
Clin Exp Med; 2024 Jul; 24(1):143. PubMed ID: 38960935
[TBL] [Abstract] [Full Text] [Related]
2. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
3. Metabolism, toxicity and management of fruquintinib: a novel drug for metastatic colorectal cancer.
Patell K; Mears VL; Storandt MH; Mahipal A
Expert Opin Drug Metab Toxicol; 2024 Apr; 20(4):197-205. PubMed ID: 38497279
[TBL] [Abstract] [Full Text] [Related]
4. RFC5, regulated by circ_0038985/miR-3614-5p, functions as an oncogene in the progression of colorectal cancer.
Yao H; Zhou X; Zhou A; Chen J; Chen G; Shi X; Shi B; Tai Q; Mi X; Zhou G; Wang S; Sun J; Yang X; Yang Y; Cao H; Zhou D; Sun L; Yao Y; He S
Mol Carcinog; 2023 Jun; 62(6):771-785. PubMed ID: 36988339
[TBL] [Abstract] [Full Text] [Related]
5. The association of blood ctDNA levels to mutations of marker genes in colorectal cancer.
Bai F; Du Q; Zou Q; Xu L; Dong W; Lv X; Han X; Zhou H; Zhang C; Lu T
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1782. PubMed ID: 36746394
[TBL] [Abstract] [Full Text] [Related]
6. Retrospective Analysis of Treatment Pathways in Patients With BRAF
Gerger A; Eisterer W; Fuxius S; Bastian S; Koeberle D; Welslau M; Sanoyan DA; Maas C; Uhlig J; Fenchel K; Greil R; VON DER Heyde E; Agocs GR; Weide R; Schwager M; Reichenbach F; Modest DP; Fritsch R
Anticancer Res; 2022 Oct; 42(10):4773-4785. PubMed ID: 36191968
[TBL] [Abstract] [Full Text] [Related]
7. Intestinal Perforation in a Patient with Colon cancer during Treatment with Regorafenib: A Case Report and Review of the Literature.
Ouchi R; Okada K; Usui K; Kurata N; Suzuki S; Nagao M; Watanabe Y; Koyama K
Tohoku J Exp Med; 2021 Jul; 254(3):207-211. PubMed ID: 34321384
[TBL] [Abstract] [Full Text] [Related]
8. Up-to-date role of aflibercept in the treatment of colorectal cancer.
Saoudi Gonzalez N; Salvà F; Ros J; Baraibar I; Marmolejo D; Valdivia A; Cuadra-Urteaga JL; Mulet N; Tabernero J; Élez E
Expert Opin Biol Ther; 2021 Oct; 21(10):1315-1324. PubMed ID: 34085884
[No Abstract] [Full Text] [Related]
9. Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinoma.
Sacdalan DB; Mendoza MJ; Vergara JP; Catedral LI; Ting FI; Leones LM; Berba CM; Sacdalan DL
Med Oncol; 2020 Nov; 37(11):106. PubMed ID: 33135102
[TBL] [Abstract] [Full Text] [Related]
10. TIPE regulates vegfr2 expression and promotes angiogenesis in colorectal cancer.
Zhong M; Li N; Qiu X; Ye Y; Chen H; Hua J; Yin P; Zhuang G
Int J Biol Sci; 2020; 16(2):272-283. PubMed ID: 31929755
[No Abstract] [Full Text] [Related]
11. Relationship between SDC1 and cadherin signalling activation in cancer.
Liao S; Liu C; Zhu G; Wang K; Yang Y; Wang C
Pathol Res Pract; 2020 Jan; 216(1):152756. PubMed ID: 31810587
[TBL] [Abstract] [Full Text] [Related]
12. Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung.
Djureinovic D; Pontén V; Landelius P; Al Sayegh S; Kappert K; Kamali-Moghaddam M; Micke P; Ståhle E
BMC Cancer; 2019 Jul; 19(1):741. PubMed ID: 31357969
[TBL] [Abstract] [Full Text] [Related]
13. Anti-colorectal cancer Effect via Application of Polyethylene Glycol Modified Liposomal Apatinib.
Hu Y; Zhou P; Lin Y; Yang D; Wang B
J Biomed Nanotechnol; 2019 Jun; 15(6):1256-1266. PubMed ID: 31072433
[TBL] [Abstract] [Full Text] [Related]
14. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
Liu Y; Li Y; Hou R; Shu Z
J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
[TBL] [Abstract] [Full Text] [Related]
15. The Prognostic Value of the Combination of Low vegfr-1 and High vegfr-2 Expression in Endothelial Cells of colorectal cancer.
D'Haene N; Koopmansch C; Van Eycke YR; Hulet F; Allard J; Bouri S; Rorive S; Remmelink M; Decaestecker C; Maris C; Salmon I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423986
[TBL] [Abstract] [Full Text] [Related]
16. [The impact of genetic variation of kdr on clinical outcomes of advanced colorectal cancer patients treated by first line bevacizumab based regimens].
Wang HX; Mei X; Gong TX; Han N; Liu P; Wang J; Zhang ZM
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(34):2737-2742. PubMed ID: 30220171
[No Abstract] [Full Text] [Related]
17. Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients.
Delgado-Ureña M; Ortega FG; de Miguel-Pérez D; Rodriguez-Martínez A; García-Puche JL; Ilyine H; Lorente JA; Exposito-Hernandez J; Garrido-Navas MC; Delgado-Ramirez M; Serrano MJ
J Transl Med; 2018 Sep; 16(1):251. PubMed ID: 30189880
[TBL] [Abstract] [Full Text] [Related]
18. Effective treatment of apatinib in desmoplastic small round cell tumor: a case report and literature review.
Shi C; Feng Y; Zhang LC; Ding DY; Yan MY; Pan L
BMC Cancer; 2018 Mar; 18(1):338. PubMed ID: 29587657
[TBL] [Abstract] [Full Text] [Related]
19. vegfr2 regulates endothelial differentiation of colon cancer cells.
Liu Z; Qi L; Li Y; Zhao X; Sun B
BMC Cancer; 2017 Aug; 17(1):593. PubMed ID: 28854900
[TBL] [Abstract] [Full Text] [Related]
20. CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.
Cortés-Guiral D; Pastor-Iodate C; Díaz Del Arco C; Del Puerto-Nevado L; Fernández-Aceñero MJ
Pathol Res Pract; 2017 Jun; 213(6):639-642. PubMed ID: 28551384
[TBL] [Abstract] [Full Text] [Related]
[Next]
